Carigent is a privately held biotechnology firm located in New Haven, CT dedicated to the development of next-generation therapeutic agents using a propriety platform that is extremely versatile and robust.

The platform allows for controlled release of therapeutic agents, tethering of surface ligands, targeting of therapy to a particular physiological site, and the ability to combine multiple agents into one vehicle made primarily from FDA-approved materials.